Asaf Madi, PhD
Anti-tumor immunotherapy enlists the patient’s own immune response to fight cancer. The immune response involves many different cell types, and for the immune system to remember its previous encounters with cancer and with infectious disease, a special class of cells called “memory T cells” must be activated. Dr. Madi and his team aim to identify these memory cells at the earliest stage of their development and determine the signals required for their activation, revealing potential targets for therapeutic translation.
